95.23 - 97.14
55.47 - 103.81
1.63M / 1.80M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-18.59%
Negative revenue growth while RGLD stands at 3.81%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-16.62%
Negative gross profit growth while RGLD is at 1.46%. Joel Greenblatt would examine cost competitiveness or demand decline.
-15.52%
Negative EBIT growth while RGLD is at 1.68%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-15.52%
Negative operating income growth while RGLD is at 1.68%. Joel Greenblatt would press for urgent turnaround measures.
-18.77%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-18.92%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-18.92%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
0.05%
Share count expansion well above RGLD's 0.01%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
0.11%
Slight or no buyback while RGLD is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
-44.76%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
-6.99%
Negative OCF growth while RGLD is at 7.47%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
31.55%
Positive FCF growth while RGLD is negative. John Neff would see a strong competitive edge in net cash generation.
13.95%
10Y revenue/share CAGR under 50% of RGLD's 127.77%. Michael Burry would suspect a lasting competitive disadvantage.
12.85%
5Y revenue/share CAGR under 50% of RGLD's 46.90%. Michael Burry would suspect a significant competitive gap or product weakness.
42.63%
3Y revenue/share CAGR at 50-75% of RGLD's 73.96%. Martin Whitman would question if the firm lags behind competitor innovations.
-5.57%
Negative 10Y OCF/share CAGR while RGLD stands at 136.79%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
21.90%
Below 50% of RGLD's 134.11%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
82.91%
3Y OCF/share CAGR under 50% of RGLD's 190.17%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
-21.60%
Negative 10Y net income/share CAGR while RGLD is at 162.60%. Joel Greenblatt sees a major red flag in long-term profit erosion.
59.10%
Below 50% of RGLD's 134.01%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
290.73%
3Y net income/share CAGR 75-90% of RGLD's 366.29%. Bill Ackman might push for an operational plan to match or beat the competitor’s short-term growth.
86.13%
10Y equity/share CAGR above 1.5x RGLD's 44.81%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
18.37%
5Y equity/share CAGR 1.25-1.5x RGLD's 12.47%. Bruce Berkowitz confirms if reinvested profits or buybacks explain the superior buildup.
14.03%
3Y equity/share CAGR at 50-75% of RGLD's 20.52%. Martin Whitman sees a short-term lag in net worth creation vs. the competitor.
323.53%
10Y dividend/share CAGR above 1.5x RGLD's 171.83%. David Dodd checks if the firm's robust cash flows justify outpacing the competitor's increases.
190.02%
5Y dividend/share CAGR above 1.5x RGLD's 30.23%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
66.46%
3Y dividend/share CAGR above 1.5x RGLD's 19.85%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
-24.73%
Firm’s AR is declining while RGLD shows 10.20%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
280.32%
We show growth while RGLD is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
1.09%
Asset growth well under 50% of RGLD's 5.81%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
0.97%
Under 50% of RGLD's 2.03%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-7.67%
We’re deleveraging while RGLD stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
-36.65%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.